3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit

  • 16-17 October 2019
  • Berlin, Germany

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit is dedicated to current challenges, best practices and inside views of the future of microbiome-based products.

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit covers topics such as:

  • CMC strategies to successfully develop live biotherapeutic products (LBPs)
  • Emerging tech and developments to bring to the market efficient and safe microbiome products
  • Critical considerations to design clinical trials for microbiome products GMP manufacturing and scale up considerations related to LBPs Commercialisation of microbiome-based diagnostics, therapies and service
  • Regulatory perspective on probiotics, LBPs and FMTs

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit brings together attendees involved or interested in:

  • Alzheimer’s
  • Ageing
  • Atherosclerosis
  • Antimicrobials
  • Bacteriotherapy
  • Autologous
  • Biology
  • Biofuels
  • Bone Marrow Transplantation
  • Bioreactors
  • Cell Culture
  • Bulk Material
  • Clinical Trial
  • Clinical Development
  • Commercialisation
  • CMO
  • Cytokines
  • Confocal Microscopy
  • Drug Delivery
  • Delivery
  • Endocrinology
  • Ecology
  • Filtration
  • Faecal Microbiota
  • Fusobacteria
  • FMT
  • Genomics
  • Gastrointestinal
  • Gut-Brain Axis
  • GMP
  • IBS
  • Hypertension
  • In Vitro
  • Immuno-Inflammation
  • Inflammation
  • IND
  • Isolation
  • Invention
  • Lifesciences
  • LBPs
  • Lyophiliser
  • Live Cell Therapeutics
  • Metagenomic
  • Medicinal Chemistry
  • Microbiota
  • Microbiology
  • Mucosal Immunology
  • Microganisms
  • Nutraceuticals
  • NASH
  • Oncoviruses
  • Nutrition
  • Phages
  • Pathogen
  • Process Cultivation
  • Prebiotics
  • Quality Control
  • Production
  • Sequencing
  • Regulatory
  • Symbiosys
  • Small Molecule
  • Testing
  • Synthetic Biology
  • Vaccines
  • Translational Sciences
  • Western Blotting
  • Analytical
  • ALS
  • Autoimmune
  • Aseptic
  • Biochemistry
  • Bacteriology
  • Biomarker
  • Bioinformatics
  • Bowel Syndrome
  • Biotechnology
  • CGMP
  • Cell Biology
  • CMC
  • Clinical Study
  • Computational Biology
  • CNS
  • Delivery
  • Contract Manufacturing
  • Dysbiosis
  • DNA
  • Epidemiology
  • Eligobiotics
  • Flow Cytometry
  • Fermentation
  • Gastroenterology
  • Freeze Drying
  • GI
  • Genome Sequencing
  • High Throughput Screening
  • Gut
  • ICH
  • IBD
  • In Vivo
  • Immuno-Oncology
  • Intellectual Property
  • Infectious Disease
  • Laboratory
  • Investment
  • Live Biotherapeutics
  • Licensing
  • Manufacturing
  • Liver Disease
  • Metatranscriptomics
  • Mergers & Acquisition
  • Microbiotherapy
  • Microbiome
  • Multiple Sclerosis
  • Molecular Biology
  • Nutrients
  • Neurodegenerative
  • Patent
  • Obesity
  • Pre-Clinical
  • PCR
  • Product Development
  • Probiotics
  • R&D
  • QA
  • Skin
  • Safety
  • Synbiotics
  • SOP
  • Tissue Culture
  • Technology Transfer
  • Viruses
  • Ulcerative Colitis
  • Yeast

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit will be held in Berlin, Germany on 16-17 October 2019.

Venue

Berlin,
Germany
  View all Hotels near Venue
Booking.com
1195-1795 Euro
Vonlanthen Group of Companies
Rentalcars Savings

Future Events

  • 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit - 16-17 Oct 2019, Berlin, Germany (85955)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories